Back to Search
CRAIG JANUARY, MD PHD
MD PHD
Clinical Cardiac Electrophysiology Physician
NPI: 1801862818IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Cardiac Electrophysiology PhysicianPrimary
Internal Medicine — Clinical Cardiac Electrophysiology
Code: 207RC0001X
36210(WI)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
36210(WI)
CMS Specialties
PrimaryCARDIAC ELECTROPHYSIOLOGY
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Class of 1976
Research & Publications (20)
Small GTPase determinants for the Golgi processing and plasmalemmal expression of human ether-a-go-go related (hERG) K+ channels.
PMID 19029296·J Biol Chem·2009
8-other
Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.
PMID 11196567·J Cardiovasc Electrophysiol·2000
6-review
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
PMID 19592609·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Is ranolazine an antiarrhythmic drug?
PMID 18375723·Am J Physiol Heart Circ Physiol·2008
7-preclinical
Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.
PMID 17965736·Br J Pharmacol·2008
8-other
International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.
PMID 18663380·Br J Pharmacol·2008
7-preclinical
Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome.
PMID 18551196·J Clin Invest·2008
5-case
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function.
PMID 17998470·Circulation·2007
8-other
Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
PMID 16967046·Br J Pharmacol·2006
5-case
HERG trafficking and pharmacological rescue of LQTS-2 mutant channels.
PMID 16610352·Handb Exp Pharmacol·2006
6-review
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
PMID 16432067·Circulation·2006
8-other
Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
PMID 16314852·Br J Pharmacol·2006
4-observational
Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and I(Kr).
PMID 16227340·Am J Physiol Heart Circ Physiol·2006
4-observational
Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
PMID 15851652·Mol Pharmacol·2005
4-observational
Blockade of HERG cardiac K+ current by antifungal drug miconazole.
PMID 15778703·Br J Pharmacol·2005
8-other
Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome.
PMID 15711590·Br J Pharmacol·2005
8-other
Pharmacological rescue of trafficking defective HERG channels formed by coassembly of wild-type and long QT mutant N470D subunits.
PMID 15072950·Am J Physiol Heart Circ Physiol·2004
8-other
Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.
PMID 14975928·Am J Physiol Heart Circ Physiol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (086) 263-1530
Quick Facts
- NPI
- 1801862818
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile